Isolated Hypoxic Hepatic Perfusion With Orthograde or Retrograde Flow in Patients With Irresectable Liver Metastases Using Percutaneous Balloon Catheter Techniques: A Phase I and II Study
- 1 June 2004
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (6) , 598-605
- https://doi.org/10.1245/aso.2004.09.021
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: Prospects and future directionsSeminars in Oncology, 2002
- Hepatic-arterial chemotherapyThe Lancet Oncology, 2001
- New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancerThe Lancet Oncology, 2001
- Tumor Necrosis Factor-α Augments Tumor Effects in Isolated Hepatic Perfusion With Melphalan in a Rat Sarcoma ModelJournal of Immunotherapy, 2000
- Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalanBritish Journal of Cancer, 1997
- Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusionBritish Journal of Cancer, 1991
- Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancerBritish Journal of Cancer, 1991
- A comparative study of isolated liver perfusion versus hepatic artery infusion with mitomycin C in ratsBritish Journal of Cancer, 1990
- Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal CancerArchives of Surgery, 1990
- A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver MetastasesAnnals of Surgery, 1987